The Third Time is the Charm for Sanofi in its IPR Challenge of Immunex’s ʼ487 Patent

February 27, 2019

Sandoz Files Declaratory Judgment of Non-Infringement For Filgrastim-Related Patent

February 22, 2019

The PTAB Denies Institution of Two IPRs Involving a Patent Directed to the Treatment of Hemophilia B

January 31, 2019

FDA Issues Guidance Documents on the “Deemed to be a License” Transition Provision of the BPCIA

January 16, 2019

FDA Proposes Amendment to the Definition of “Biological Product”

January 7, 2019

AbbVie Files Suit Against Sandoz Alleging Infringement of Two Humira®-Related Patents

August 14, 2018

Genentech Files Suit Alleging Eli Lilly’s Taltz® Product Infringes a Newly Issued Genentech Patent

July 16, 2018

Genentech Files Two New Lawsuits Against Celltrion Alleging Infringement of Patents Related to Rituxan® and Herceptin®

July 12, 2018

Lilly Announces Positive Results for Galcanezumab in Treating Episodic Cluster Headaches

May 25, 2018

Novartis and Amgen Announce FDA Approval of Aimovig™

May 23, 2018